# Suzhou Amerigen Pharmaceutical Co., Ltd. – FDA Inspection, Oct 25, 2017

Source: https://www.keypedia.com/records/fda_inspections/suzhou-amerigen-pharmaceutical-co-ltd/8ce0a023-cf80-41aa-b1c5-d71baf38fe4d
Source feed: FDA_Inspections

> FDA inspection 1030228 of Suzhou Amerigen Pharmaceutical Co., Ltd., October 25, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030228
- Company Name: Suzhou Amerigen Pharmaceutical Co., Ltd.
- Inspection Date: 2017-10-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 992992 - 2016-11-11](https://www.keypedia.com/records/fda_inspections/suzhou-amerigen-pharmaceutical-co-ltd/d137c4f6-ea68-4e76-8f21-7875963cbff9)
- FDA Inspection 935610 - 2015-06-19
- FDA Inspection 852974 - 2013-07-19
- FDA Inspection 617851 - 2009-09-03

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/suzhou-amerigen-pharmaceutical-co-ltd/bb075ce7-9b71-429a-94ae-1d5714c5047a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c